H-RAS gene expression in human multinodular goiter

Area of Science:

• Endocrinology
• Molecular Biology
• Oncology

Background:

• The RAS protooncogene plays a role in neoplasia, but its function in thyroid neoplasia is not fully established.
• Thyroid nodular goiters can be classified as toxic or nontoxic, potentially involving different molecular mechanisms.

Purpose of the Study:

• To evaluate H-RAS mRNA and protein levels in human nontoxic and toxic multinodular goiter samples.
• To investigate the correlation between H-RAS expression and thyroid status (serum TSH levels).

Main Methods:

• Quantitative analysis of H-RAS mRNA and protein expression in human thyroid tissue samples.
• Comparison of H-RAS levels between nodular and nonnodular tissues in nontoxic and toxic multinodular goiters.
• Correlation analysis between H-RAS expression and thyroglobulin expression.

Main Results:

• Significantly increased H-RAS mRNA levels were observed in nontoxic multinodular goiter nodules compared to nonnodular tissue (P=0.016).
• Approximately 50% of nontoxic multinodular goiter specimens showed increased H-RAS mRNA, paralleled by increased protein levels in 90% of cases.
• No significant differences in H-RAS expression were found in toxic multinodular goiters, and none exhibited H-RAS overexpression. H-RAS expression correlated positively with thyroglobulin (r2=0.51; P=0.04).

Conclusions:

• Increased H-RAS mRNA and protein levels in nontoxic multinodular goiter suggest its involvement in goiter pathogenesis.
• The absence of H-RAS overexpression in toxic multinodular goiter indicates distinct molecular pathways in thyroid nodular disease based on thyroid status.